From a recent Hewlett-Packard press release:
PALO ALTO, Calif., May 11, 1998 - Hewlett-Packard Company and
Caliper Technologies Corp.
today announced they have signed an agreement to develop jointly the
first-generation of analytical instrumentation and information systems
based on Caliper's lab-on-chip technology.
Lab-on-a-chip technology. The image conjures up visions of microprocessors
whipping through complex sample prep, separation, detection, and spectrum
analysis tasks at unheard of speeds while analysts need only wait
milliseconds for the results.
In fact, unreal as it seems, that is exactly what is happening, right now.
And that's just the beginning. Because when the first analytical task is
done, the analyst then replaces instrument's central microchip with a new
one designed to perform a different task, and throws the old chip away.
Disposable microchips. Not even Intel has managed that trick.
What we're talking about here is microfluidics, an idea whose time has
definitely arrived.
Applying ideas originally explored at Oak Ridge National Laboratories,
the University of Alberta, and Ciba Geigy, among other places, Caliper
Technologies has developed a series of practical applications for
microfluidics technology. Taken together, these will enable the first
major advance in lab practice since Louis Pasteur first started puddling
around with test tubes and beakers just like the ones you're using today.
Using miniature, integrated biochemical processing systems etched
into glass, silion, quartz or plastic, Caliper's lab chips allow the same
steps customarily performed in conventional instruments to be done in
minute quantities at small fractions of the usual elapsed time.
The "micro" in microfluidics refers not only to lab chip dimensions, but
to the quantities being manipulated. Microchip channels are on the order
of 80 microns wide and 10 microns deep. The fluids move through at
nanoliter/second rates.
By applying voltages to various channel intersections, the chip moves
an analyte through the system, adjusting its concentration across three
orders of magnitude, mixing it with buffers, separating out the constituents,
adding fluorescent tags and directing the sample past detection devices.
"It's really a micro-robot," observes Caliper's Mike Knapp. "It's
actually doing the experiment. It's not a real-time replacement for a
pipette, it's a robotic system working on a nano scale."
Like its microprocessor counterpart, the microfluidic chip's output is
digital. As a result of lab chip instrumentation, says marketing guru
Regis McKenna, "the bioinformation database becomes a font of knowledge
for leveraging drug discovery, biochemical tests and other types of
chemical and biochemical experiments and tests."
"We think a combination of microfluidics technology and micro-
electromechanical (MEM) sensor technology, applied over time, will
enable the individual researcher to have an entire synthesis-analysis-
screening facility on their desktop," HP's Vince Dauciunas predicts.
"We think it has the power to speed things up exponentially."
Both Caliper and Hewlett-Packard are excited about the synergy generated
by their collaboration. Caliper will manufacture the actual microfluidics
chip sets themselves and supply them exclusively to HP for insertion into
the instrumentation systems. HP will take responsibility for the
manufacturing of the instrumentation, the marketing, the distribution
and the support of the entire system product.
As Dauciunas points out, the early developments won't radically change
the researcher's life. "She'll put this instrument, about the size of a
UV-Vis system, on her desktop and do enzyme kinetics or maybe DNA sizing
experiments. What will be different is that, by simply changing the chip,
she can rapidly reconfigure for different types of experiments without
having to reinvest in a completely different system."
The chip, the consumable that goes with the instrument, programs the
device for the experiment at hand. So there will be no need to invest
in five or six different types of instruments to conduct a range of
experiments.
"Eventually, you'll have arrays of multi-purpose workstations around
the lab," says Knapp, "and chips on hand which will convert them from,
say, a flow cytometer in the morning to a DNA sequencer in the afternoon."
In combination with DNA array technology, microfluidics has the
possibility to radically improve the accuracy of diagnostic tests.
Instead of relying on a visual confirmation via a microscope, or a
three-day culture test, DNA arrays supported by microfluidics will
present a completely unambiguous detection. "It offers the promise of a
hand-held genetic analysis down at the point-of-care center," says Dauciunas.
Recollecting Thomas Edison, Knapp says, "Research is supposed to be 1%
inspiration and 99% perspiration. The real revolution here is that people
will now be able to spend more time thinking about their information and
way less time generating it."
Says Dauciunas, "What you're seeing is kind of like the Wright
brothers flyer…and looking down the road 50 years to a 747. Except
this is going to be a 10 or 12 year journey, not a 50 year journey."
|